Discover 1,431 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,431
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Halifax, Moncton, Rimouski, Farmington CT, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase 3, Recruiting
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
for
Peritoneal Carcinomatosis, Appendiceal Neoplasms,
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal
Sex: All
Age: 18+
Code: NCT05913674
Phase 2, Recruiting
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
for
Rheumatoid Arthritis, Ankylosing Spondylitis,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18+
Code: NCT03729674
Recruiting
Impact of a Paced Breathing Exercise Intervention on Autonomic Nervous System Function After Pediatric Concussion
for
Concussion, Mild
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 9 - 18
Code: NCT06559865
Recruiting
Comparison of the Analgesic Effect of 2 Shoulder Infiltrations
for
Infiltration, Shoulder Osteoarthritis
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 20+
Code: NCT05408065
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
for
Systemic Sclerosis With Lung Involvement, Systemic Sclerosis,
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT05785065
Phase 2, Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant